The Profound Impacts of Precision Medicine, Genomic Sequencing on Cancer Care
Precision Oncology is helping NCI treat cancer based on specific genetic changes in a patient’s tumor by allowing them to target mutations that will lower toxicity and improve overall effectiveness of the treatment.
A clinical trial at the National Cancer Institute called NCI-MATCH showed how cancer patients could benefit from genomic sequencing and is now informing future trials on precision medicine.
The NCI Molecular Analysis for Therapy Choice Trial initially screened 6,000 patients and treated 1,300 of them by pairing certain medications with their specific tumors regardless of the cancer type. Future trials like ComboMATCH will now look at precision medicine to study how tumors respond to targeted treatments.
NCI Researchers Dr. Lindsay Harris and Dr. Peter O’Dwyer shared how precision oncology is expanding treatment options and increasing patients’ survival rates. They also discuss the importance of clinical trials like these for progressing the fight against cancer.
-
Dr. Lyndsay Harris Associate Director, Cancer Diagnosis Program NCI -
Dr. Peter O'Dwyer Group Co-Chair ECOG-ACRIN Cancer Research Group
-
USPIS Uses AI to Advance Criminal Investigations
The U.S. Postal Inspection Service is using AI to uncover crime patterns, support investigations and improve workforce efficiency.
5m watch -
Advice for the Next Generation of Cybersecurity Professionals
Author Agathe Merle discussed breaking barriers in cybersecurity, fostering inclusion and using creativity to strengthen cyber defense.
29m watch -
How Army Contracting Command is Using AI in Acquisition
Army Contracting Command’s Jordan Duke discusses AI adoption, cybersecurity risks and securing acquisition operations across the Army enterprise.
9m watch -
Treasury's Data Transparency Push Brings 250 Years of Federal Finance Into Focus
Justin Cole discusses Treasury's new data initiative, AI's role in public access, and why trusted government financial data remains essential.
10m listen
